These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 16708647)

  • 1. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].
    Yoshihara Y; Yamada H
    Clin Calcium; 2007 Apr; 17(4):500-8. PubMed ID: 17404478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
    Murphy G; Nagase H
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):128-35. PubMed ID: 18253109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
    Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
    J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head.
    Di Girolamo N; Wakefield D; Coroneo MT
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4142-9. PubMed ID: 11095607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S; Murray GI
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain.
    Dzwonek J; Rylski M; Kaczmarek L
    FEBS Lett; 2004 Jun; 567(1):129-35. PubMed ID: 15165905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
    Mannello F
    Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases involvement in pathologic conditions.
    Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
    Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.